(1) Oncology Drugs: $29.3 billion (45%)
(2) In Vitro Diagnostics: $13.7 billion (21%)
(3) Immunology Drugs: $8.8 billion (13%)
(4) Other Therapeutic Drugs: $5.9 billion (9%)
(5) Neuroscience Drugs: $5.3 billion (8%)
(6) Ophthalmology Drugs: $1.7 billion (3%)
(7) Infectious Diseases Drugs: $1.1 billion (2%)
------------------------------------------------------------------------------
TOTAL Revenues in 2020: $65.8 billion
WHAT HAS CHANGED?
From 2017-2020
Change in Oncology Drugs: $2.6 billion
+ Change in In Vitro Diagnostics: $1.7 billion
+ Change in Immunology Drugs: $0.9 billion
+ Change in Other Therapeutic Drugs: $2.2 billion
+ Change in Neuroscience Drugs: $3.7 billion
+ Change in Ophthalmology Drugs: $0.3 billion
+ Change in Infectious Diseases Drugs: $-0.3 billion
------------------------------------------------------------------------------
TOTAL Change 2017-2020: $11.0 billion
+ Roche's Revenues in 2017: $54.9 billion
= TOTAL Revenues in 2020: $65.8 billion